The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy

Journal of Ultrasound in Medicine

Volumn 26, Issue 8, 2007, Pages 1055-1063

  Chen, Min Hua ^a,b   Wu, Wei ^a   Yang, Wei ^a   Dai, Ying ^a   Gao, Wen ^a   Yin, Shan Shan ^a   Yan, Kun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma; Indications; Radio frequency ablation therapy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DRUG THERAPY; PATIENT MONITORING; TUMORS;

CONTRAST-ENHANCED ULTRASONOGRAPHY; HEPATOCELLULAR CARCINOMA; RADIO FREQUENCY ABLATION THERAPY;

BIOMEDICAL ENGINEERING;

CONTRAST MEDIUM; SONOVUE; SULFUR HEXAFLUORIDE;

AGED; ARTICLE; CANCER PATIENT; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; TECHNIQUE; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 34547689002     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.8.1055     Document Type: Article

References (28)

1. McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001; 176:3-16.
2. Chen MH, Yang W, Yan K, et al. Protocol for radiofrequency ablation of large liver tumors and its clinical application in 110 patients. Radiology 2004; 232:260-271.
3. Kettenbach J, Köstler W, Rücklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 2003; 180:1537-1545.
4. Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002; 8:1165-1174.
5. Koda M, Ueki M, Maeda Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004; 183:583-588.
6. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-768.
7. Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001; 136:864-869.
8. Bleicher RJ, Allegra D, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10:52-58.
9. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17:684-692.
10. Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006; 141:581-587.
11. Kudo M. Early detection and curative treatment of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 2005; 3(suppl 2):S144-S148.
12. Chen MH, Yang W, Yan K, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006; 17:671-683.
13. Chen MH, Dai Y, Yan K, et al. Early diagnosis of small hepatocellular carcinoma in patients with cirrhosis using contrast-enhanced ultrasound. Chin J Ultrasonogr 2005; 14:116-120.
14. Nicolau C, Catalá V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14:1092-1099.
15. Leen E, Angerson WJ, Yarmenitis S, et al. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002; 41:200-206.
16. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232:420-430.
17. von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23:1557-1568.
18. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51 (suppl):S19-S23.
19. Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol 2004; 14(suppl 8):34-42.
20. Vilana R, Bianchi L, Varela M, et al. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 2006; 16:2454-2462.
21. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56:66-73.
22. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and control of percutaneous treatments with contrast-enhanced ultrasound. Eur Radiol 2003; 13(suppl 3):N87-N90.
23. Dill-Macky MJ, Asch M, Burns P, Wilson S. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186(suppl):S287-S295.
24. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221:447-454.
25. Tamai H, Oka M, Maeda H, et al. Contrast harmonic sonographically guided radio frequency ablation for spontaneous ruptured hepatocellular carcinoma. J Ultrasound Med 2005; 24:1021-1026.
26. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004; 183:153-156.
27. Dodd GD III, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20:9-27.
28. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J 2000; 6(suppl 4):304-315.